Tuxarin 8 mg/1
codeine phosphate and chlorpheniramine maleate · TABLET, EXTENDED RELEASE · Mainpointe Pharmaceuticals
Tuxarin is a tablet, extended release containing codeine phosphate and chlorpheniramine maleate at 8 mg/1, taken oral. Manufactured by Mainpointe Pharmaceuticals.
Key Facts
- Brand Name
- Tuxarin
- Generic Name
- codeine phosphate and chlorpheniramine maleate
- NDC Code (Product)
71269-040- Manufacturer
- Mainpointe Pharmaceuticals
- Strength
- 8 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule III (Controlled)
- Application #
- NDA206323
- Marketing Start
- 10/15/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Tuxarin used for?
Tuxarin contains codeine phosphate and chlorpheniramine maleate. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is Tuxarin a controlled substance?
Yes, Tuxarin is classified as CIII under the DEA Controlled Substances Act.
What is the generic name for Tuxarin?
The generic name for Tuxarin is codeine phosphate and chlorpheniramine maleate. There are no other listed brand versions of codeine phosphate and chlorpheniramine maleate.
What is the NDC code for Tuxarin 8 mg/1?
The NDC (National Drug Code) for Tuxarin 8 mg/1 is 71269-040, listed by Mainpointe Pharmaceuticals.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)